SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950137-03-004099
Filing Date
2003-08-06
Accepted
2003-08-06 10:11:40
Documents
7
Period of Report
2003-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q c78678e10vq.htm 10-Q 180519
3 EX-11 COMPUTATION OF EARNINGS PER SHARE c78678exv11.htm EX-11 19612
4 EX-12 COMPUTATION OF RATIO OF EARNINGS TO CHARGES c78678exv12.htm EX-12 18095
5 EX-31.1 RULE 13A-14(A) CERTIFICATION OF CEO c78678exv31w1.htm EX-31.1 6556
6 EX-31.2 RULE 13A-14(A) CERTIFICATION OF CFO c78678exv31w2.htm EX-31.2 6546
7 EX-32 SECTION 1350 CERTIFICATION c78678exv32.htm EX-32 5257
8 EX-99 CAUTIONARY STATEMENT UNDER REFORM ACT c78678exv99.htm EX-99 8280
  Complete submission text file 0000950137-03-004099.txt   247255
Mailing Address LILLY CORPORATE CENTER DROP CODE 1112 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1112 INDIANAPOLIS IN 46285 3172762000
LILLY ELI & CO (Filer) CIK: 0000059478 (see all company filings)

IRS No.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-06351 | Film No.: 03825218
SIC: 2834 Pharmaceutical Preparations